Phase 3 clinical trial

July 31, 2017July 31, 2017

Revefenacin May Be Potential Treatment for COPD Patients, Phase 3 Clinical Trial Shows

COPD, News

Treatment with revefenacin (TD-4208) has shown promise in a Phase 3 clinical trial (NCT02518139) with chronic obstructive pulmonary disease (COPD) patients, said Theravance Biopharma and Mylan. Revefenacin is an investigational long-acting ... Read more

July 8, 2016July 8, 2016

Actelion Begins Phase 3 Study of Opsumit as Possible Treatment for Children with PAH

News, Pulmonary Hypertension

Actelion announced the launch of a Phase 3 clinical trial evaluating the effectiveness of a pediatric formulation of Opsumit (macitentan) in delaying disease progression in children with pulmonary arterial hypertension (PAH). Opsumit is an orally available ... Read more

April 14, 2016April 14, 2016

Phase 3 Trial of Brigatinib for Non-Small Cell Lung Cancer Linked to ALK Mutations Is Launched by ARIAD

Lung Cancer, News

ARIAD Pharmaceuticals recently announced the start of a Phase 3 clinical trial of brigatinib for locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults with mutations in the anaplastic ... Read more

October 13, 2015October 13, 2015

LabCorp Diagnostic Test for PD-L1 is Approved by FDA for Nivolumab-Treated NSCLC Patients

Lung Cancer, News

Laboratory Corporation of America Holdings (LabCorp), a leading healthcare diagnostics company, announced that the FDA has approved a new diagnostic test for patients with non-small cell lung cancer (NSCLC). The test was used ... Read more